Join the global community of corporate and public-sector finance industry leaders reading Global Finance monthly in print.

Click Here

Capital Raising & Corporate Finance

Scottish Skills Continue To Attract FDI

Scotland still brings in more foreign direct investment than many larger countries. Last year it again headed the list of top UK destinations outside London.

Capital Raising & Corporate Finance

Will Japanese Companies Bow To Shareholders?

Management | Corporate Governance Japanese corporate culture, long considered one of the least shareholder-friendly among developed nations, may be softening up, with a little nudge from prime minister Shinzo Abe.

Banking

Blockchain Technology | Banking On Bitcoin

Special Report | Bitcoin Cryptocurrencies like Bitcoin that exchange digital information are a disruptive area for banks. The industry at first dismissed such currencies, but is now looking at how Bitcoin could change their business.

Capital Raising & Corporate Finance

CEO Pay Disclosure Shadows Public Companies

SEC & Executive Compensation | Five years after the 2010 Dodd-Frank financial reform act, several of its controversial corporate governance provisions on executive compensation continue to wend their way through the system.

Capital Raising & Corporate Finance

CFOs Put Big Data Into Action

Big Data | Chief financial officers have been modeling profit and loss statements for years, but in an era of big data they face a different and increasingly complex task.

Capital Raising & Corporate Finance

Ford’s Swaps Vehicle Passes CFTC Inspection

Capital Markets | Derivatives Life may have just become a bit easier for finance executives at companies with captive finance units—which is to say, almost all automakers and scores of equipment manufacturers.

Capital Raising & Corporate Finance

Israel’s Teva Bids $40 Billion For US Generic-Drug Rival

Capital Markets | M&A Pharmaceuticals In what could become Israel’s biggest cross-border M&A deal ever, Teva Pharmaceutical Industries made an unsolicited $40 billion offer to acquire Mylan, a Pennsylvania-based drugmaker registered in the Netherlands with operational headquarters in the UK.
arrow-chevron-right-redarrow-chevron-rightbutton-arrow-left-greybutton-arrow-left-red-400button-arrow-left-red-500button-arrow-left-red-600button-arrow-left-whitebutton-arrow-right-greybutton-arrow-right-red-400button-arrow-right-red-500button-arrow-right-red-600button-arrow-right-whitecaret-downcaret-rightclosecloseemailfacebook-square-holdfacebookhamburger-newhamburgerinstagramlinkedin-square-1linkedinpauseplaysearch-outlinesearchsubscribe-digitalsubscribe-printtwitter-square-holdtwitteryoutube